Advances in Molecular Pathology reviews the year’s most important findings and updates within the field in order to provide practitioners with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Ahmad Abou Tayoun, identifies key areas of major progressand controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in molecular pathology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Advances in Inherited Bone Marrow Failure Syndromes: Clinical Manifestations, Genetics, and Diagnostic Approaches Advances in Prenatal Genomic Sequencing Role of Long-read Sequencing in Comprehensive Genomic Profiling of Hematolymphoid Malignancies DNA Methylation-Based Profiling in Mature B-cell Neoplasms Emerging Biomarkers in Non-small Cell Lung Cancer: ERBB2 and MET Amplifications Perspectives on Homologous Recombination Repair Deficiency (HRD): Updates on Testing to Treatments A Review of Molecular Techniques and Biomarkers for the Diagnosis of Tumors of the Central Nervous System Economic Analysis of Pharmacogenomics: Challenges and Progress A Beginner’s Guide to Assay Development for Emerging Pathogens Current State of Metagenomics for Infectious Diseases Diagnosis: Limitations and Future Directions Molecular Detection of Antimicrobial Resistance Markers, Clinical Application, and Limitations Health Disparities and Precision Medicine The Near Future of Cancer Cytogenetics: Whole Genome Sequencing, Long-Read Sequencing, or Optical Genome Mapping? Economics of Molecular Pathology
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.